These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35460023)

  • 21. Linking
    Nguyen V; Bevernage J; Darville N; Tistaert C; Van Bocxlaer J; Rossenu S; Vermeulen A
    Mol Pharm; 2021 Mar; 18(3):952-965. PubMed ID: 33400546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osmotic load from glucose polymers.
    Koo WW; Poh D; Leong M; Tam YK; Succop P; Checkland EG
    JPEN J Parenter Enteral Nutr; 1991; 15(2):144-7. PubMed ID: 2051555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osmolality/osmolarity data and calculations.
    Schott H
    Pharmazie; 1979 Apr; 34(4):257-9. PubMed ID: 482340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitations of methods of osmometry: measuring the osmolality of biological fluids.
    Sweeney TE; Beuchat CA
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R469-80. PubMed ID: 8456999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Investigation of Cellular Effects of Polyethylene Glycol (PEG) Derivatives.
    Pham Le Khanh H; Nemes D; Rusznyák Á; Ujhelyi Z; Fehér P; Fenyvesi F; Váradi J; Vecsernyés M; Bácskay I
    Polymers (Basel); 2022 Jan; 14(2):. PubMed ID: 35054686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of measured and calculated osmolality levels.
    Kar E; Kocatürk E; Küskü Kiraz Z; Demiryürek B; Alataş IÖ
    Clin Exp Nephrol; 2020 May; 24(5):444-449. PubMed ID: 31983046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of formulation excipients with proteins in solution and in the dried state.
    Ohtake S; Kita Y; Arakawa T
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1053-73. PubMed ID: 21756953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmolality of substances used in the intensive care nursery.
    Ernst JA; Williams JM; Glick MR; Lemons JA
    Pediatrics; 1983 Sep; 72(3):347-52. PubMed ID: 6889039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat.
    Chamanza R; Darville N; van Heerden M; De Jonghe S
    Toxicol Pathol; 2018 Jan; 46(1):85-100. PubMed ID: 29096596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of serum and plasma osmolality in healthy young humans--influence of time and storage conditions.
    Seifarth CC; Miertschischk J; Hahn EG; Hensen J
    Clin Chem Lab Med; 2004; 42(8):927-32. PubMed ID: 15387444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A New Model for Non-Lipid Compounded Neonatal Parenteral Nutrition Solution Osmolality.
    Borenstein S; Mack E; Palmer K; Cat T; Gibson LC; Sandhu M; Wang J; Simmons CF
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1075-1083. PubMed ID: 30133841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals.
    Feng Y; Meng Y; Tan F; Lv L; Li Z; Wang Y; Yang Y; Gong W; Yang M
    Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of polyethylene glycol molecular weight and concentration on lactate dehydrogenase activity in solution and after freeze-thawing.
    Mi Y; Wood G; Thoma L; Rashed S
    PDA J Pharm Sci Technol; 2002; 56(3):115-23. PubMed ID: 12109331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fast membrane osmometer as alternative to freezing point and vapor pressure osmometry.
    Grattoni A; Canavese G; Montevecchi FM; Ferrari M
    Anal Chem; 2008 Apr; 80(7):2617-22. PubMed ID: 18315010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Freeze-thaw stability of aluminum oxide nanoparticles.
    Trenkenschuh E; Friess W
    Int J Pharm; 2021 Sep; 606():120932. PubMed ID: 34310956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of the best equation for plasma osmolality calculation: Comparison of fourteen formulae.
    Martín-Calderón JL; Bustos F; Tuesta-Reina LR; Varona JM; Caballero L; Solano F
    Clin Biochem; 2015 May; 48(7-8):529-33. PubMed ID: 25794428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations.
    Thakral S; Sonje J; Munjal B; Suryanarayanan R
    Adv Drug Deliv Rev; 2021 Jun; 173():1-19. PubMed ID: 33741437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of Formulations of Commercially Available Antibodies.
    Strickley RG; Lambert WJ
    J Pharm Sci; 2021 Jul; 110(7):2590-2608.e56. PubMed ID: 33789155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.